Video Experimental Relacionado
Updated: Jul 16, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Tecno.Visión.Visión de la tecnología. Terapia génica, terapia de genes, terapia de genes, terapia de genes, terapia
Kelly K Hunt1, Stephan A Vorburger
1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. khunt@mdanderson.org
Science (New York, N.Y.)
|July 20, 2002
Resumen
La terapia génica es prometedora para el tratamiento del cáncer, con más de 500 ensayos clínicos en curso. Los desafíos clave incluyen la mejora de la entrega de genes, la orientación tumoral y la reducción de la toxicidad para mejores resultados de la terapia génica del cáncer.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Biotecnología La biotecnología es la biotecnología.
Sus antecedentes:
- La terapia génica ha experimentado avances significativos en la última década, con más de 500 protocolos de terapia génica que entran en ensayos clínicos.
- A pesar del progreso, los ensayos clínicos han revelado varios obstáculos que deben abordarse para una terapia génica eficaz contra el cáncer.
Objetivo del estudio:
- Para delinear las áreas críticas para el avance de la terapia génica del cáncer.
- Discutir estrategias para mejorar la entrega de genes, la orientación tumoral y la ventana terapéutica.
- Posicionar la terapia génica como un enfoque complementario dentro del panorama más amplio del tratamiento del cáncer.
Principales métodos:
- Centrarse en el desarrollo de nuevos vectores para mejorar la entrega de genes.
- Investigación de agentes de unión selectivos para tumores para una orientación precisa del cáncer.
- Estrategias para optimizar la ventana terapéutica, minimizando la toxicidad en las terapias combinadas.
Principales resultados:
- Identificación de los desafíos clave en los ensayos clínicos actuales de terapia génica.
- Destacando la necesidad de mejorar los vectores, los mecanismos de orientación y la gestión de la toxicidad.
- Haciendo hincapié en la integración de la terapia génica con los tratamientos convencionales.
Conclusiones:
- La terapia génica del cáncer requiere más investigación sobre el desarrollo del vector, la especificidad del tumor y los perfiles de seguridad.
- La terapia génica debe verse como un complemento, no un reemplazo, de los tratamientos contra el cáncer existentes.
- El objetivo es mejorar el arsenal terapéutico con enfoques de terapia génica racionales, molecularmente guiados.
Videos de Conceptos Relacionados
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...